Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shingo Hachinohe"'
Autor:
Tohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh-Yoneyama, Taku Yoshiya, Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki, Shingo Hachinohe, Shintaro Ishiyama, Motohiro Nonaka, Michiko N. Fukuda, Chikara Ohyama
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Background p-Boronophenylalanine (10BPA) is a powerful 10B drug used in current clinical trials of BNCT. For BNCT to be successful, a high (500 mg/kg) dose of 10BPA must be administered over a few hours. Here, we report BNCT efficacy after r
Externí odkaz:
https://doaj.org/article/a8a6401007f9447bab9c5194fe2dff25
Autor:
Tohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Taku Yoshiya, Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki, Shingo Hachinohe, Shintaro Ishiyama, Motohiro Nonaka, Michiko N. Fukuda, Chikara Ohyama
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-5 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/a1d6f3d092594bd5b59f80670477a420
Autor:
Ishiyama Shintaro, Michiko N. Fukuda, Mihoko Sutoh Yoneyama, Chikara Ohyama, Takehiro Ishizu, Shingo Hachinohe, Tohru Yoneyama, Motohiro Nonaka, Tsuyoshi Uemura, Minoru Suzuki, Taku Yoshiya, Shingo Hatakeyama
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-5 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Autor:
Tohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Taku Yoshiya, Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki, Shingo Hachinohe, Shintaro Ishiyama, Motohiro Nonaka, Michiko N. Fukuda, Chikara Ohyama
Publikováno v:
Journal of Urology. 207
Autor:
Chikara Ohyama, Shingo Hachinohe, Mihoko Sutoh Yoneyama, Minoru Suzuki, Ishiyama Shintaro, Tohru Yoneyama, Shingo Hatakeyama, Michiko N. Fukuda, Tsuyoshi Uemura, Taku Yoshiya, Takehiro Ishizu, Motohiro Nonaka
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
Background p-Boronophenylalanine (10BPA) is a powerful 10B drug used in current clinical trials of BNCT. For BNCT to be successful, a high (500 mg/kg) dose of 10BPA must be administered over a few hours. Here, we report BNCT efficacy after rapid, ult
Autor:
Tohru, Yoneyama, Shingo, Hatakeyama, Mihoko, Sutoh Yoneyama, Taku, Yoshiya, Tsuyoshi, Uemura, Takehiro, Ishizu, Minoru, Suzuki, Shingo, Hachinohe, Shintaro, Ishiyama, Motohiro, Nonaka, Michiko N, Fukuda, Chikara, Ohyama
Publikováno v:
BMC Cancer
p-Boronophenylalanine ((1) IF7 conjugates of eitherIntravenous injection of IF7C conjugates of eitherWe conclude that IF7 serves as an efficient